Artificial intelligence is reshaping data management across regulated industries, and life sciences is no exception. In this session, Egnyte’s experts will share our vision for AI in life sciences, highlighting how our secure, purpose-built AI engines are enhancing compliance, governance, and collaboration without compromising data privacy. We will explore the evolution of Egnyte’s machine learning models, our commitment to client data security, AI’s growing role across regulated industries, and the potential of AI-driven regulatory intelligence for clinical trials.

Many biotech companies struggle with managing massive amounts of data without an established governance process. Join Dr. Rebecca Carazza as she discusses how Nimbus Therapeutics addresses the complexity of managing over a decade of accumulated unstructured data by leveraging Egnyte to transform its data governance collaboration. During her presentation, Dr. Carazza will also highlight some key challenges encountered during this transition and the strategies Nimbus Therapeutics is implementing to overcome them.

Emerging biotech companies face a critical challenge: managing complex data and processes effectively. Join Daniel Dacey, Founder and CEO of Dovetail Biopartners, as he highlights the impacts of data silos on today's biotechs and how implementing foundational data governance practices can improve operational and scientific excellence to support better clinical outcomes.